Post by
FerrariPalmbeac on Jun 15, 2017 1:34pm
Valeant to present at the Goldman Sachs Conference. June 20
LAVAL, Quebec, May 31, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Paul Herendeen, executive vice president and chief financial officer, and Linda LaGorga, senior vice president, finance and treasurer, are scheduled to present at the following financial Conferences Goldman Sachs Second Annual Leveraged Finance Conference on Tuesday, June 20, 2017 at 10:40 a.m. PDT (1:40 p.m. EDT) at Terranea, Rancho Palos Verde, Calif. A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: https://ir.valeant.com/events-and-presentations About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com. Contact Information Investors: Elif McDonald elif.mcdonald@valeant.com 514-856-3855 877-281-6642 (toll free) Media: Lainie Keller lainie.keller@valeant.com 908-927-0617 Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/) To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-present-at-financial-industry-conferences-300466400.html SOURCE Valeant Pharmaceuticals International, Inc.
Comment by
Joe454 on Jun 15, 2017 2:37pm
This post has been removed in accordance with Community Policy